Innate Pharma SA Additions Other Than Through Business Combinations Intangible Assets Other Than Goodwill
Innate Pharma SA (IPHA) reported Additions Other Than Through Business Combinations Intangible Assets Other Than Goodwill of EUR 0 for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Notes › Intangible Assets
ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill · last filed 2026-04-01
| Period end | Additions Other Than Through Business Combinations Intangible Assets Other Than Goodwill 6 month | Additions Other Than Through Business Combinations Intangible Assets Other Than Goodwill 12 month |
|---|---|---|
| 2025-12-31 | 0.00 EUR 20-F · filed 2026-04-01 | |
| 2025-06-30 | 0.00 EUR 6-K · filed 2025-09-17 | |
| 2024-12-31 | 0.00 EUR 20-F · filed 2026-04-01 | |
| 2024-06-30 | 0.00 EUR 6-K · filed 2025-09-17 | |
| 2023-12-31 | 2.00M EUR 20-F · filed 2026-04-01 | |
| 2023-06-30 | 2.00M EUR 6-K · filed 2024-09-12 | |
| 2022-12-31 | 587.00K EUR 20-F · filed 2025-04-30 | |
| 2022-06-30 | 0.00 EUR 6-K · filed 2023-09-14 | |
| 2021-12-31 | 368.00K EUR 20-F · filed 2024-04-04 | |
| 2021-06-30 | 0.00 EUR 6-K · filed 2022-09-15 | |
| 2020-12-31 | 3.69M EUR 20-F · filed 2023-04-06 | |
| 2020-06-30 | 3.69M EUR 6-K · filed 2021-09-15 | |
| 2019-12-31 | 27.02M EUR 20-F · filed 2022-04-04 |